• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有相反共轭键极性的甲氨蝶呤/明胶共轭物的表征及甲氨蝶呤的体外释放

Characterization and in vitro methotrexate release from methotrexate/gelatin conjugates of opposite conjugate bond polarity.

作者信息

Bowman B J, Ofner C M

机构信息

Department of Pharmaceutical Sciences, Philadelphia College of Pharmacy, University of the Sciences in Philadelphia, PA 19104, USA.

出版信息

Pharm Res. 2000 Oct;17(10):1309-15. doi: 10.1023/a:1026460023503.

DOI:10.1023/a:1026460023503
PMID:11145239
Abstract

PURPOSE

Our laboratory has previously prepared gelatin/ methotrexate (MTX) conjugates containing mixed conjugation sites and by-product crosslinking, both of which may alter conjugate effectiveness. In this study, we prepared and evaluated gelatin/MTX conjugates having specific conjugate bond sites and minimal by-product crosslinking.

METHODS

Opposite polarity conjugates were produced by coupling gelatin having blocked amino groups with MTX (G-MTX) and by coupling MTX having blocked amino groups with gelatin (M-GEL) using 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide HCl. Amino groups were blocked using citraconic anhydride and deblocked under acidic conditions. Gelatin and MTX contents were determined spectrophotometrically. The stability of each conjugate was determined by evaluating their in vitro release of MTX in isotonic buffer at pH 7.4 and 37 degrees C for 7 days.

RESULTS

The G-MTX and M-GEL conjugates contained 21 and 1.2 mole MTX/mole gelatin and released 12 and 17% MTX by 7 days resulting in pseudo-first order release rate constants of 0.76x10(-3) and 1.0x10(-3) hr(-1), respectively. Alternate MTX species (< or =10%) were detected during the release study and were attributed to low molecular weight gelatin/MTX fragments and MTX polymers.

CONCLUSIONS

Gelatin/MTX conjugates having opposite conjugate bond polarities and minimal by-product crosslinking have been produced and slowly released MTX by hydrolytic cleavage indicating good stability for future cell culture studies.

摘要

目的

我们实验室之前制备了含有混合共轭位点和副产物交联的明胶/甲氨蝶呤(MTX)共轭物,这两者都可能改变共轭物的有效性。在本研究中,我们制备并评估了具有特定共轭键位点且副产物交联最少的明胶/MTX共轭物。

方法

使用1-乙基-3-(3-二甲基氨基丙基)碳二亚胺盐酸盐,通过将具有封闭氨基的明胶与MTX偶联(G-MTX)以及将具有封闭氨基的MTX与明胶偶联(M-GEL)来制备相反极性的共轭物。使用柠康酸酐封闭氨基,并在酸性条件下解封。通过分光光度法测定明胶和MTX的含量。通过评估它们在pH 7.4和37℃的等渗缓冲液中7天的MTX体外释放来确定每种共轭物的稳定性。

结果

G-MTX和M-GEL共轭物分别含有21和1.2摩尔MTX/摩尔明胶,到7天时释放了12%和17%的MTX,导致假一级释放速率常数分别为0.76×10⁻³和1.0×10⁻³小时⁻¹。在释放研究期间检测到了替代的MTX种类(≤10%),这归因于低分子量的明胶/MTX片段和MTX聚合物。

结论

已经制备了具有相反共轭键极性且副产物交联最少的明胶/MTX共轭物,并通过水解裂解缓慢释放MTX,表明其对于未来的细胞培养研究具有良好的稳定性。

相似文献

1
Characterization and in vitro methotrexate release from methotrexate/gelatin conjugates of opposite conjugate bond polarity.具有相反共轭键极性的甲氨蝶呤/明胶共轭物的表征及甲氨蝶呤的体外释放
Pharm Res. 2000 Oct;17(10):1309-15. doi: 10.1023/a:1026460023503.
2
Characterization and in vitro release of methotrexate from gelatin/methotrexate conjugates formed using different preparation variables.使用不同制备变量形成的明胶/甲氨蝶呤缀合物中甲氨蝶呤的表征及体外释放
Int J Pharm. 2000 Aug 25;204(1-2):81-9. doi: 10.1016/s0378-5173(00)00476-2.
3
Growth inhibition, drug load, and degradation studies of gelatin/methotrexate conjugates.明胶/甲氨蝶呤缀合物的生长抑制、药物负载及降解研究
Int J Pharm. 2006 Feb 3;308(1-2):90-9. doi: 10.1016/j.ijpharm.2005.10.037. Epub 2005 Dec 19.
4
Polyethylene glycol conjugates of methotrexate varying in their molecular weight from MW 750 to MW 40000: synthesis, characterization, and structure-activity relationships in vitro and in vivo.甲氨蝶呤的聚乙二醇缀合物,分子量在750至40000之间:体外和体内的合成、表征及构效关系
Bioconjug Chem. 2002 Jul-Aug;13(4):773-85. doi: 10.1021/bc010098m.
5
Gelatin-methotrexate conjugate microspheres as a potential drug delivery system.明胶-甲氨蝶呤共轭微球作为一种潜在的药物递送系统。
J Pharm Sci. 2006 Sep;95(9):1896-908. doi: 10.1002/jps.20572.
6
The effect of molecular weight, drug load, and charge of gelatin-MTX conjugates on growth inhibition of HL-60 leukemia cells.明胶-甲氨蝶呤共轭物的分子量、药物负载量及电荷对HL-60白血病细胞生长抑制的影响。
Pharm Res. 2009 Feb;26(2):338-45. doi: 10.1007/s11095-008-9746-5. Epub 2008 Oct 31.
7
Methotrexate esters of poly(ethylene oxide)-block-poly(2-hydroxyethyl-L-aspartamide). Part I: Effects of the level of methotrexate conjugation on the stability of micelles and on drug release.聚(环氧乙烷)-嵌段-聚(2-羟乙基-L-天冬酰胺)的甲氨蝶呤酯。第一部分:甲氨蝶呤缀合水平对胶束稳定性和药物释放的影响。
Pharm Res. 2000 May;17(5):607-11. doi: 10.1023/a:1007529218802.
8
Synthesis and characterization of methotrexate polyethylene glycol esters as a drug delivery system.甲氨蝶呤聚乙二醇酯作为药物递送系统的合成与表征
Chem Pharm Bull (Tokyo). 2010 Feb;58(2):147-53. doi: 10.1248/cpb.58.147.
9
Synthesis and properties of a biodegradable polymer-drug conjugate: Methotrexate-poly(glycerol adipate).甲氨蝶呤-聚(己二酸甘油酯)的可生物降解聚合物-药物偶联物的合成与性质。
Colloids Surf B Biointerfaces. 2018 Jul 1;167:115-125. doi: 10.1016/j.colsurfb.2018.03.048. Epub 2018 Mar 28.
10
A novel method to prepare magnetite chitosan microspheres conjugated with methotrexate (MTX) for the controlled release of MTX as a magnetic targeting drug delivery system.一种制备与甲氨蝶呤(MTX)偶联的磁性壳聚糖微球的新方法,用于作为磁性靶向给药系统控制释放MTX。
Drug Deliv. 2009 Jul;16(5):280-8. doi: 10.1080/10717540902989555.

引用本文的文献

1
Pharmacokinetics and Biodistribution of Pegylated Methotrexate after IV Administration to Mice.聚乙二醇化甲氨蝶呤静脉注射给小鼠后的药代动力学和生物分布
Iran J Pharm Res. 2018;17(Suppl2):111-123.
2
Carbodiimide induced cross-linking, ligand addition, and degradation in gelatin.碳二亚胺诱导明胶发生交联、配体添加及降解。
Mol Pharm. 2015 Mar 2;12(3):783-93. doi: 10.1021/mp5006118. Epub 2015 Feb 6.
3
Preparation, drug release, and cell growth inhibition of a gelatin: doxorubicin conjugate.明胶-阿霉素缀合物的制备、药物释放和细胞生长抑制。

本文引用的文献

1
Characterization and in vitro release of methotrexate from gelatin/methotrexate conjugates formed using different preparation variables.使用不同制备变量形成的明胶/甲氨蝶呤缀合物中甲氨蝶呤的表征及体外释放
Int J Pharm. 2000 Aug 25;204(1-2):81-9. doi: 10.1016/s0378-5173(00)00476-2.
2
Cytotoxic and antitumor effect of fibrinogen-methotrexate conjugate.纤维蛋白原-甲氨蝶呤缀合物的细胞毒性和抗肿瘤作用。
Cancer Lett. 2000 Feb 1;148(2):189-95. doi: 10.1016/s0304-3835(99)00334-1.
3
Phagocytosis of cross-linked gelatin matrix by human breast carcinoma cells correlates with their invasive capacity.
Pharm Res. 2013 Aug;30(8):2087-96. doi: 10.1007/s11095-013-1065-9. Epub 2013 May 18.
4
The effect of molecular weight, drug load, and charge of gelatin-MTX conjugates on growth inhibition of HL-60 leukemia cells.明胶-甲氨蝶呤共轭物的分子量、药物负载量及电荷对HL-60白血病细胞生长抑制的影响。
Pharm Res. 2009 Feb;26(2):338-45. doi: 10.1007/s11095-008-9746-5. Epub 2008 Oct 31.
人乳腺癌细胞对交联明胶基质的吞噬作用与其侵袭能力相关。
Clin Cancer Res. 1998 Feb;4(2):507-15.
4
The loading rate determines tumor targeting properties of methotrexate-albumin conjugates in rats.负载率决定了甲氨蝶呤 - 白蛋白缀合物在大鼠体内的肿瘤靶向特性。
Anticancer Drugs. 1997 Aug;8(7):677-85.
5
Influence of carrier on biodistribution and in vitro cytotoxicity of methotrexate-branched polypeptide conjugates.载体对甲氨蝶呤-支链多肽缀合物生物分布及体外细胞毒性的影响。
Bioconjug Chem. 1993 Jan-Feb;4(1):25-33. doi: 10.1021/bc00019a004.
6
Potentiation of in vivo antitumor effects of recombinant interleukin-1 alpha by gelatin conjugation.通过与明胶结合增强重组白细胞介素-1α的体内抗肿瘤作用。
Jpn J Cancer Res. 1993 Jun;84(6):681-8. doi: 10.1111/j.1349-7006.1993.tb02029.x.
7
Suppressive effect of recombinant TNF-gelatin conjugate on murine tumour growth in-vivo.重组肿瘤坏死因子-明胶缀合物对小鼠体内肿瘤生长的抑制作用。
J Pharm Pharmacol. 1993 Apr;45(4):303-8. doi: 10.1111/j.2042-7158.1993.tb05557.x.
8
The methotrexate story: a paradigm for development of cancer chemotherapeutic agents.甲氨蝶呤的故事:癌症化疗药物研发的范例。
Adv Enzyme Regul. 1994;34:397-419. doi: 10.1016/0065-2571(94)90025-6.
9
Controlled release systems for proteins based on gelatin microspheres.基于明胶微球的蛋白质控释系统。
J Biomater Sci Polym Ed. 1994;6(5):391-8. doi: 10.1163/156856294x00383.
10
Macromolecular drug carrier systems in cancer chemotherapy: macromolecular prodrugs.癌症化疗中的大分子药物载体系统:大分子前药
Crit Rev Oncol Hematol. 1995 Mar;18(3):207-31. doi: 10.1016/1040-8428(94)00131-c.